Bionote slashs IPO price to 9,000 won, 50% lower than previous valuation
Ye-Jin Jun
Dec 13, 2022 (Gmt+09:00)
Everybody is aware that investment fever on biotech firms has already cooled due to rising interest rates and concerns over the fizzling economy, and Bionote, South Korea's in-vitro diagnostics ...